On 5 December 2023, Alzheimer Europe (AE) hosted a Company Round Table meeting in Brussels. The meeting was a hybrid event, with many participants attending in person and some joining remotely. It was attended by company representatives from Alzheon, Biogen, Bristol Myers Squibb, Eli Lilly, EFPIA, Essity, Novo Nordisk, Nutricia and Roche, members of the AE staff and members of the AE Board. During the meeting, four speakers provided updates on recent policy and research developments.
First, Cindy Birck, AE Project Officer, gave an update on our Clinical Trials Watch. Next, Angela Bradshaw, AE Director for Research and Policy, presented the AE Call for Action on anti-amyloid treatments. Owen Miller, AE Project Officer, shared then some updates on EU policy developments and European Parliament elections.
Finally, Jean Georges, AE Executive Director, informed participants about Alzheimer Europe’s activities in 2023 and the work plan and sponsorship opportunities for 2024. He also presened the future directions of the AE Company Round Table Meetings and opened the discussion with the audience. We would like to thank our sponsors and members for participating in this meeting and we look forward to welcoming them to the next Company Round Table meeting in March.
